Skip to content

In the BioHarmony Drug Report Database

Tiotropium

Spiriva, Spiriva Respimat (tiotropium) is a small molecule pharmaceutical. Tiotropium was first approved as Spiriva on 2004-01-30. It is used to treat chronic bronchitis and pulmonary emphysema in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M1, and muscarinic acetylcholine receptor M4. Spiriva handihaler's patents are valid until 2030-10-16 (FDA).
Trade Name Spiriva, Spiriva Respimat
Common Name Tiotropium
Indication chronic bronchitis, pulmonary emphysema
Drug Class Quaternary ammonium derivatives; atropine derivatives
Tiotropium
Get full access now